Perrigo (PRGO) Misses Q2 EPS by 5c; Guides FY16 EPS Below Views

Perrigo Company plc Reports Second Quarter 2016 Financial Results

August 10, 2016 6:29 AM EDT

DUBLIN, Aug. 10, 2016 /PRNewswire/ --

Delivered second quarter reported (GAAP) net sales of $1.48 billion and adjusted (non-GAAP) net sales of $1.44 billion, excluding sales of $44 million from held-for-sale businesses* Delivered second quarter reported net income of $194 million and reported diluted earnings per share of $1.35; delivered second quarter reported gross margin of 38.3%, and second quarter reported operating margin of 16.1% Realized adjusted net income of $278 million and adjusted diluted earnings per share of $1.93; achieved second quarter adjusted gross margin of 48.0% with second quarter adjusted operating margin of 27.3% Consumerfacing businesses achieved reported net... More

Perrigo Completes The Divestiture Of Its Vitamins, Minerals & Supplements Business To IVC

August 8, 2016 8:12 AM EDT

DUBLIN, Aug. 8, 2016 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has completed the previously announced divestiture of its U.S. Vitamins, Minerals & Supplements (VMS) business to International Vitamin Corporation (IVC).

About Perrigo

Perrigo Company plc is a top five global over-the-counter ("OTC") consumer goods and leading specialty pharmaceutical company, offering patients and customers high- quality products at affordable prices. From the Company's beginning in 1887 as a packager of home remedies, it has grown to become the... More